Biotech China 2014

Oncology: New York University

Total Score People Score Events Score
13 9 9
Date Event Presentation Speakers
April 6, 2013 AACR Annual Meetings Metabolic Changes Associated with Ras-Drive Cancers Chairperson: Dafna Bar-Sagi, New York University Langone Medical Center, New York, NY Dafna Bar-Sagi
September 13, 2012 International Society of Gastrointestinal Oncology Session 3 | Advanced Colon Cancer Howard S. Hochster
EGFR inhibitors Howard S. Hochster
January 21, 2010 2010 DERMATOLOGY FOUNDATION CLINICAL SYMPOSIA: ADVANCES IN DERMATOLOGY Therapeutics Forum Seth J. Orlow
October 1, 2009 6TH ANNUAL MEETING OF THE INTERNATIONAL SOCIETY OF GASTROINTESTINAL ONCOLOGY (ISGIO) Panel Discussion With Interactive Q/A Howard S. Hochster
Curable Metastatic Colorectal Cancer Howard S. Hochster
October 22, 2008 HDAC Inhibitors: Targeting Oncology and Beyond Discovery, Preclinical and Initial Phase I Development of CS055/HBI-8000, a Novel Benzamide Class HDAC Inhibitor Michael J. Newman
March 25, 2008 PATHWAY ANALYSIS Melanoma and microRNA Eva M Hernando
March 25, 2008 CANCER MOLECULAR MARKERS Melanoma and microRNA Eva M Hernando
November 6, 2007 Chemotherapy Foundation Symposium XXV CHEMOIMMUNOTHERAPY REINDUCTION WITH EPRATUZUMAB IN CHILDREN WITH RELAPSED ALL Elizabeth Raetz
EXPANDING ROLE OF CETUXIMAB IN THE FIRST AND SECOND-LINE THERAPY OF COLORECTAL CANCER Howard S. Hochster
PEGYLATED LIPOSOMAL DOXORUBICIN: DOSE-SCHEDULING, COMBINATIONS AND MAINTENANCE Franco M. Muggia
NEW AGENTS AND COMBINATIONS Anna C. Ferrari
PRELIMINARY RESULTS OF GENASENSE, TEMOZOLOMIDE & ABRAXANE COMBINATION IN ADVANCED MELANOMA Anna Pavlick
October 11, 2007 Sixth International Colorectal Cancer Congress Optimal Dosing and Scheduling of Anti-EGFR Therapy Howard S. Hochster
Moving EGFR Inhibitors to the Front-line and Further: Are We Ready Yet? Howard S. Hochster
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.